Stephanie Oestreich is Executive Vice President at Evotec and leads BRIDGEs Partnerships for North America and Asia, negotiating umbrella agreements with universities and financing partners, selecting novel research projects and starting companies or licensing successful opportunities to pharma or biotech after achieving proof of concept: https://www.evotec.com/en/innovate/bridges She is also a director on the board of three private companies (Epigene Labs, MindMics and Autobahn Labs), and the Boston Philharmonic Orchestra. Previously, she was International Business Leader at F. Roche Hoffmann-La Roche Ltd., growing the blockbuster Avastin breast, cervical and ovarian cancer indications by 10%. She also successfully launched 4 oncology and immunology drugs and held local, regional and global marketing roles with increasing responsibilities in different geographies and therapeutic areas at Novartis. Before working in Strategic Alliances at Novartis, she conducted the research for her PhD in biochemistry at Harvard Medical School and obtained an MPA from the Harvard Kennedy School. As a semi-professional violinist, she has performed with members of the Berlin, Vienna, and Boston Philharmonic Orchestra in Carnegie Hall and demonstrates the analogies of teams and leadership in music and management in presentations with the Kendall Square Orchestra, an orchestra of scientists that she co-founded: www.kendallsquareorchestra.org.